Ralentissez la progression de la myopiegrâce aux verres Stellest® d'Essilor®

Faites le premier pas contre la myopie.

La nouvelle génération de la prise en charge de la myopie

Des lunettes blanches transparentes, entourées de lumières bleues et vertes.

En 2020, Essilor® a lancé la première génération de verres Essilor® Stellest®, qui ralentissent la progression de la myopie de 67 % en moyenne, venant ainsi en aide à des millions d'enfants à travers le monde.

Fort du succès de la génération précédente, les verres Essilor® Stellest® 2.0 offrent une efficacité doublée, ralentissant la croissance de l'œil 1,88 fois plus qu'avec la génération précédente.

Bénéfices des verres Essilor Stellest 2.0​

Cercle vert

Deux fois la puissance1, une efficacité accrue

dans la gestion de la progression de la myopie23

Cercle noir

Correction de la myopie​

conçus pour offrir une vision nette grâce à la prescription de votre enfant45

Cercle vert

Aucun compromis :

esthétiques, simples et sûrs6

Pourquoi choisir les verres EssilorStellest 2.0 pour votre enfant?

Icône « 2× »

la puissance, efficacité accrue
pour ralentir la progression de la myopie.

Icône « no 1 »

les verres de lunettes Essilor® les
plus efficaces dans la gestion de la myopie.

Icône « 6 »

Les verres Essilor® Stellest® sont
efficaces dans la gestion de la myopie chez les enfants dès l’âge de 6 ans 78

Manage myopia progression via H.A.L.T.9 MAX technology

A closer look at the technology

Essilor® Stellest® 2.0 lenses provide twice the signal for slowing myopia progression10, delivering significantly better results1112 vs the first generation of Essilor® Stellest® lenses. The enhanced efficacy of Essilor® Stellest® 2.0 lenses is supported by clinical trial results13.

  • Correct myopia
    Designed to provide sharp vision with your child's prescription
  • Myopia management
    Slow myopic eye growth with H.A.L.T. MAX technology

The evidence behind every claim

The mention "twice the power" refers to a depth of unfocused light volume (by design) twice (or more) greater than that of Essilor® Stellest® lenses, and is not associated with a doubling of lens power, microlens power or efficiency.

Based on the 12-month results of a prospective, randomized, double-blind, contralateral crossover clinical trial conducted in Singapore on 50 children.

Raveendran RN, et al. Effect of increased power and asphericity of highly aspherical lenslets on myopia control efficacy: a contralateral crossover study. Transl Vis Sci Technol. 2025;14(11):9.

No significant difference in distance BCVA between Essilor® Stellest® and Essilor® Stellest® 2.0 lenses when looking through the central zone of the lens (Drobe B, et al. Effect of increased power and asphericity of lenslets in myopia control spectacle lenses on short-term visual performance. Invest Ophthalmol Vis Sci. 2025;66:2144).

When viewed through the peripheral zone of the aspheric microlenses, no significant difference was observed between Essilor® Stellest® and Essilor® Stellest® 2.0 lenses for high-contrast, low-contrast, and low-contrast near visual acuity (VA). (EssilorLuxottica. Internal data. 2025. Impact of increased microlens power and asphericity on the short-term visual performance of myopia control lenses.)

Essilor® Stellest® 2.0 lenses are made of AIRWEAR® polycarbonate which offers impact resistance and blocks 100% of UV transmission.

Based on the 12-month results of a prospective, randomized, double-blind, contralateral crossover clinical trial conducted in Singapore on 50 children.

Raveendran RN, et al. Effect of increased power and asphericity of highly aspherical lenslets on myopia control efficacy: a contralateral crossover study. Transl Vis Sci Technol. 2025;14(11):9.

HALT stands for Highly Aspherical Lenslet Target and does not mean that the progression of myopia is "stopped" or "blocked".

The mention "twice the power" refers to a depth of unfocused light volume (by design) twice (or more) greater than that of Essilor® Stellest® lenses, and is not associated with a doubling of lens power, microlens power or efficiency.

Based on the 12-month results of a prospective, randomized, double-blind, contralateral crossover clinical trial conducted in Singapore on 50 children.

Raveendran RN, et al. Effect of increased power and asphericity of highly aspherical lenslets on myopia control efficacy: a contralateral crossover study. Transl Vis Sci Technol. 2025;14(11):9.

Raveendran RN, et al. Effect of increased power and asphericity of highly aspherical lenslets on myopia control efficacy: a contralateral crossover study. Transl Vis Sci Technol. 2025;14(11):9.

Essilor® Stellest® lenses are not currently available in all countries, including the United States, and have not been authorized by the US FDA.

Blue Light Explained

FAQs